Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of Pain PD Assessments with Remifentanil
NCT02602002Phase 1Completed
- Sponsor
- GSK
- Start
- Apr 2008
- Primary completion
- Jun 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of remifentanil in pain (2 arms), sponsored by GSK. Primary endpoint: Heat Pain Threshold. Started Apr 2008; status: completed.
02
Drugs
remifentanil
03
Conditions
pain
Beyond the preview
Go deeper on NCT02602002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02602002.